Literature DB >> 12800977

Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan.

Paul Dowling1, James Lohan, Kay Ohlendieck.   

Abstract

The cell biological hypothesis of Duchenne muscular dystrophy assumes that deficiency in the membrane cytoskeletal element dystrophin triggers a loss in surface glycoproteins, such as beta-dystroglycan, thereby rendering the sarcolemmal membrane more susceptible to micro-rupturing. Secondary changes in ion homeostasis, such as increased cytosolic Ca2+ levels and impaired luminal Ca2+ buffering, eventually lead to Ca2+-induced myonecrosis. However, individual muscle groups exhibit a graded pathological response during the natural time course of x-linked muscular dystrophy. The absence of the dystrophin isofom Dp427 does not necessarily result in a severe dystrophic phenotype in all muscle groups. In the dystrophic mdx animal model, extraocular and toe muscles are not as severely affected as limb muscles. Here, we show that the relative expression and sarcolemmal localization of the central trans-sarcolemmal linker of the dystrophin-glycoprotein complex, beta-dystroglycan, is preserved in mdx extraocular and toe fibres by means of two-dimensional immunoblotting and immunofluorescence microscopy. Thus, with respect to improving myology diagnostics, the relative expression levels of beta-dystroglycan appear to represent reliable markers for the severity of secondary changes in dystrophin-deficient fibres. Immunoblotting and enzyme assays revealed that mdx toe muscle fibres exhibit an increased expression and activity of the sarcoplasmic reticulum Ca2+-ATPase. Chemical crosslinking studies demonstrated impaired calsequestrin oligomerization in mdx gastrocnemius muscle indicating that abnormal calsequestrin clustering is involved in reduced Ca2+ buffering of the dystrophic sarcoplasmic reticulum. Previous studies have mostly attributed the sparing of certain mdx fibres to the special protective properties of small-diameter fibres. Our study suggests that the rescue of dystrophin-associated glycoproteins, and possibly the increased removal of cytosolic Ca2+ ions, might also play an important role in protecting muscle cells from necrotic changes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12800977     DOI: 10.1078/0171-9335-00315

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  11 in total

Review 1.  Proteomic profiling of x-linked muscular dystrophy.

Authors:  Caroline Lewis; Steven Carberry; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2009-12       Impact factor: 2.698

2.  Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage.

Authors:  Kevin J Morine; Meg M Sleeper; Elisabeth R Barton; H Lee Sweeney
Journal:  Hum Gene Ther       Date:  2010-12       Impact factor: 5.695

3.  Calcium-binding proteins in skeletal muscles of the mdx mice: potential role in the pathogenesis of Duchenne muscular dystrophy.

Authors:  Adriana Pertille; Candida Luiza Tonizza de Carvalho; Cintia Yuri Matsumura; Humberto Santo Neto; Maria Julia Marques
Journal:  Int J Exp Pathol       Date:  2009-12-03       Impact factor: 1.925

4.  Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy.

Authors:  Paul Dowling; Philip Doran; Kay Ohlendieck
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

5.  Isobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from mdx Mice at the Early Phase of Dystrophy.

Authors:  Cintia Yuri Matsumura; Bruno Menezes de Oliveira; Madeleine Durbeej; Maria Julia Marques
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

6.  Deficiency in Cardiac Dystrophin Affects the Abundance of the $\alpha$ -/ $\beta$ -Dystroglycan Complex.

Authors:  James Lohan; Kevin Culligan; Kay Ohlendieck
Journal:  J Biomed Biotechnol       Date:  2005

7.  Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Steven Carberry; Heinrich Brinkmeier; Yaxin Zhang; Claudia K Winkler; Kay Ohlendieck
Journal:  Int J Mol Med       Date:  2013-07-03       Impact factor: 4.101

Review 8.  Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.

Authors:  Ashling Holland; Kay Ohlendieck
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

9.  Mass spectrometric identification of dystrophin, the protein product of the Duchenne muscular dystrophy gene, in distinct muscle surface membranes.

Authors:  Sandra Murphy; Kay Ohlendieck
Journal:  Int J Mol Med       Date:  2017-07-27       Impact factor: 4.101

10.  Mass Spectrometric Profiling of Extraocular Muscle and Proteomic Adaptations in the mdx-4cv Model of Duchenne Muscular Dystrophy.

Authors:  Stephen Gargan; Paul Dowling; Margit Zweyer; Jens Reimann; Michael Henry; Paula Meleady; Dieter Swandulla; Kay Ohlendieck
Journal:  Life (Basel)       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.